Caffeine-Activated Gene Editing Could Lead to New Cancer Treatments

Texas A&M researchers develop a chemogenetic system that pairs CRISPR with caffeine to control gene editing in cells.

Mar. 3, 2026 at 7:23am

Got story updates? Submit your updates here. ›

Scientists at the Texas A&M Health Institute of Biosciences and Technology have created a new chemogenetic system that combines caffeine with the CRISPR gene editing tool. This allows them to precisely control when gene editing occurs inside targeted cells, including immune T cells that can fight cancer. The approach provides a reversible on/off switch for gene editing, potentially enabling safer and more adjustable cell and gene therapies.

Why it matters

This research could lead to new ways to treat chronic diseases like cancer and diabetes by giving scientists more precise control over gene editing in cells. The ability to activate and deactivate gene editing with a common compound like caffeine provides an accessible and potentially lower-risk approach compared to some existing therapies.

The details

The chemogenetic system developed by the Texas A&M team involves engineering cells to produce three key components: a nanobody, its matching target protein, and the CRISPR gene editing machinery. When caffeine is consumed, it causes the nanobody and target protein to bind together, activating the CRISPR system and enabling gene editing. Certain drugs like rapamycin can then be used to reverse the process and halt additional gene editing. This level of control is important for developing safe and adjustable therapies.

  • The research was published on February 27, 2026.

The players

Yubin Zhou

Professor and director of the Center for Translational Cancer Research at the Institute of Biosciences and Technology at Texas A&M University.

Texas A&M Health Institute of Biosciences and Technology

The research institution where the caffeine-activated gene editing system was developed.

Got photos? Submit your photos here. ›

What they’re saying

“What excites us is the idea of repurposing well-known drugs and even commonly found food ingredients like caffeine to do entirely new tricks. Instead of acting as therapies themselves, molecules like caffeine or rapamycin can serve as precise control signals for sophisticated cell and gene therapies.”

— Yubin Zhou, Professor and director

What’s next

The researchers plan to continue preclinical testing and investigate additional medical uses for the caffeine-activated gene editing system, with the goal of moving closer to clinical applications.

The takeaway

This innovative approach to gene editing, using a common compound like caffeine as an activation switch, opens up new possibilities for developing safer and more precisely controlled cell and gene therapies to treat complex diseases like cancer.